Hematologic Malignancies Members

Monzr M. Al Malki, M.D., is an associate professor in the Department of Hematology & Hematopoietic Cell Transplantation and is board certified in internal medicine, hematology and medical oncology at City of Hope.

Ibrahim T. Aldoss, M.D., is a hematologist-oncologist and board certified in internal medicine, medical oncology and hematology. His clinical expertise is in acute lymphoblastic leukemia and acute myeloid leukemia.

Haris Ali, M.D., is a hematologist-oncologist and associate professor in the Department of Hematology & Hematopoietic Cell Transplantation.

Brian Ball, M.D., is a hematologist-oncologist in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope.

Pamela Becker, M.D., Ph.D., is a highly respected clinician with expertise in acute myeloid leukemia, multiple myeloma, bone marrow failure and other diseases of the blood and immune system.

Rusha Bhandari, M.D., M.S., is an assistant professor in the Department of Pediatrics and Department of Populations Sciences at City of Hope.

Elizabeth Budde, M.D., Ph.D., is an oncologist and associate professor at City of Hope.

Modulation of the bone marrow niche to redirect cellular networks in stress and malignant hematopoiesis

John Chan, M.D., is a hematopathologist and co-leader of the hematology malignancies program at City of Hope Cancer Center.

Sanjeet Singh Dadwal, M.D., is chief, Division of Infectious Diseases, and professor in the Department of Medicine, with a clinical focus on infectious diseases.

Dr. Danilov is the associate director of the Toni Stephenson Lymphoma Center and professor in the Department of Hematology & Hematopoietic Cell Transplantation.

Stephen J. Forman, M.D., hematologist-oncologist, is a top cancer doctor for leukemia, lymphoma & bone marrow transplantation. He is also the director of the Hematologic Malignancies Research Institute & director of the T Cell Therapeutics Research Laboratory at City of Hope, Duarte, California.

James Godfrey, M.D., is a hematologist and assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation Department at City of Hope Duarte.

Dr. Gu’s research focus is to integrate multi-omics platforms, advanced analytical approaches, and multiple experimental models to study the heterogeneity of acute leukemias and facilitate the development of more efficacious targeted therapies.

Alex Herrera, M.D., is chief of the Division of Lymphoma and a hematologist-oncologist at City of Hope specializing in treating and researching lymphoma.

Susanta Hui, Ph.D., is a Professor, Department of Radiation Oncology at City of Hope in Duarte, CA.

Avyakta Kallam, M.D., is an assistant professor, department of Hematology and Hematopoietic Cell Transplantation.

Amrita Krishnan, M.D., directs the Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope's cancer research hospital, seeking to make gains in one of the most rapidly changing areas in cancer research.

Ya-Huei Kuo, Ph.D., is a professor in the Department of Hematologic Malignancies Translational Science with a research focus in leukemia biology.

Larry Kwak, M.D., Ph.D., is the director of the Toni Stephenson Lymphoma Center at City of Hope.

Ling Li, Ph.D., is an associate professor in Beckman Research Institute's Department of Hematologic Malignancies Translational Science.

Guido Marcucci, M.D., is professor and chair of the Department of Hematological Malignancies Translational Science and chief of the Division of Leukemia.

Lindsey Murphy, M.D., M.S., is an assistant professor in the Department of Pediatrics at City of Hope in Duarte, California.

Ryotaro Nakamura, M.D., is the Jan & Mace Siegel Professor in Hematology & Hematopoietic Cell Transplantation professor and a hematologist/oncologist at City of Hope.

Vu Nguyen Ngo, Ph.D., is an associate professor in the Department of Systems Biology at Beckman Research Institute of City of Hope.

Dr. Palmer’s research interests and effort support preclinical and clinical studies concerning the major obstacles to disease control/cure of hematologic malignancies and successful hematopoietic stem cell transplantation.

Anna Pawlowska, M.D., specializes in treating young people with leukemia and directs our Pediatric Hematopoietic Cell Transplantation Program.

Tycel Phillips, M.D., is a hematologist-oncologist in the Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, at City of Hope in Duarte, CA.

Flavia Pichiorri, Ph.D., M.S., is a professor in the Department of Hematologic Malignancies Translational Science.

Leslie Popplewell, M.D., is a hematologist specializing in lymphoma at City of Hope Atlanta.

Christiane Querfeld, M.D., Ph.D., is a dermatologist and dermatopathologist who specializes in the diagnosis and treatment of cutaneous lymphoma.

Tulio Rodriguez, M.D., is the director of Hematology, Bone Marrow Transplant and Cellular Therapy Program, City of Hope Cancer Center Chicago

Steven T. Rosen, M.D., is a professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, and executive vice president and director emeritus, Comprehensive Cancer Center and Beckman Research Institute of City of Hope.

Michael Rosenzweig, M.D., is Chief, Division of Multiple Myeloma and a hematologist-oncologist, in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, CA.

Eileen P. Smith, M.D., chair of the Department of Hematology & Hematopoietic Cell Transplantation, leads City of Hope with her expertise in hematology and oncology.

Anthony Stein, M.D., is a hematologist-oncologist who specializes in treating and researching acute myeloid leukemia.

Dr. Kambhampati Thiruvengadam is a hematologist-oncologist and assistant professor, division of Lymphoma in the Department of Hematology & Hematopoieti Cell Transplantation.

Xiuli Wang, Ph.D., is a professor in City of Hope's Department of Hematology & Hematopoietic Cell Transplantation.

Stephanie Yoon, M.D., is a radiation oncologist at City of Hope. Dr. Yoon focuses on treating breast cancer, brain tumors and spine tumors, because of the way cancer in those regions threatens the essence of what makes people who they are — their personalities, experiences, sensations and memories. 

John A. Zaia, M.D., is the director of the Center for Gene Therapy at City of Hope and has expertise in stem cell and HIV/AIDS research.

Jasmine Zain M.D., is a professor in hematology and HCT. Additionally, she is the Tim Nesvig Lymphoma Research Fellow, as well as director of the T cell Lymphoma Program at City of Hope.

Defu Zeng, is a professor of immunology & theranostics and hematologist. His focus is on transplantation immune tolerance.

Bin Zhang, Ph.D., is an associate professor in the Department of Hematologic Malignancies Translational Science.